Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.8650
+0.0153 (1.80%)
Aug 14, 2025, 11:02 AM - Market open

Estrella Immunopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
1.320.924.172.484.09-
Cash & Short-Term Investments
1.320.924.172.484.09-
Cash Growth
-68.39%-77.99%68.02%-39.36%--
Receivables
---0.27--
Prepaid Expenses
0.160.720.29-0.83-
Total Current Assets
1.481.644.452.754.92-
Long-Term Deferred Charges
---0.28--
Other Long-Term Assets
1.51.5----
Total Assets
2.983.144.453.034.92-
Accounts Payable
0.010----
Accrued Expenses
8.772.980.148.850.03-
Current Portion of Leases
-000.02--
Current Income Taxes Payable
-00.04---
Other Current Liabilities
0.30.0100.880.92-
Total Current Liabilities
9.0830.189.760.95-
Other Long-Term Liabilities
---0.010.01-
Total Liabilities
9.0830.189.770.96-
Common Stock
00000-
Additional Paid-In Capital
26.0824.6424.120.450.03-
Retained Earnings
-31.58-23.93-19.5-12.19-1.07-
Treasury Stock
-0.6-0.57-0.35---
Total Common Equity
-6.090.144.27-11.74-1.04-
Shareholders' Equity
-6.090.144.27-6.743.96-
Total Liabilities & Equity
2.983.144.453.034.92-
Total Debt
-000.02--
Net Cash (Debt)
1.320.914.162.464.09-
Net Cash Growth
-68.36%-78.06%69.36%-39.90%--
Net Cash Per Share
0.040.030.158.04--
Filing Date Shares Outstanding
37.0736.1736.1935.20.18-
Total Common Shares Outstanding
37.0736.1936.294.060.18-
Working Capital
-7.59-1.364.27-7.013.97-
Book Value Per Share
-0.160.000.12-2.89-5.91-
Tangible Book Value
-6.090.144.27-11.74-1.04-
Tangible Book Value Per Share
-0.160.000.12-2.89-5.91-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q